300 related articles for article (PubMed ID: 28098112)
1. Autosomal dominant polycystic kidney disease: Study of clinical characteristics in an Indian population.
Vikrant S; Parashar A
Saudi J Kidney Dis Transpl; 2017; 28(1):115-124. PubMed ID: 28098112
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
Miskulin DC; Abebe KZ; Chapman AB; Perrone RD; Steinman TI; Torres VE; Bae KT; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Moore CG; Flessner MF; Schrier RW;
Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
[TBL] [Abstract][Full Text] [Related]
3. Clinical manifestations of autosomal dominant polycystic kidney disease in patients older than 50 years.
Milutinovic J; Fialkow PJ; Agodoa LY; Phillips LA; Rudd TG; Sutherland S
Am J Kidney Dis; 1990 Mar; 15(3):237-43. PubMed ID: 2137671
[TBL] [Abstract][Full Text] [Related]
4. Abdominal sonographic study of autosomal dominant polycystic kidney disease.
Nicolau C; Torra R; Bianchi L; Vilana R; Gilabert R; Darnell A; Brú C
J Clin Ultrasound; 2000; 28(6):277-82. PubMed ID: 10867665
[TBL] [Abstract][Full Text] [Related]
5. Autosomal dominant polycystic kidney disease in Colombia.
Camargo JT; González CA; Herrera L; Yomayusa-González N; Ibañez M; Valbuena-García AM; Acuña-Merchán L
BMC Nephrol; 2023 Jul; 24(1):211. PubMed ID: 37460967
[TBL] [Abstract][Full Text] [Related]
6. Autosomal dominant polycystic kidney disease.
Srivastava A; Patel N
Am Fam Physician; 2014 Sep; 90(5):303-7. PubMed ID: 25251090
[TBL] [Abstract][Full Text] [Related]
7. Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease.
Kocyigit I; Ozturk F; Eroglu E; Karaca Z; Kaynar AS; Cetin M; Tokgoz B; Sipahioglu MH; Bayramov R; Sen A; Oymak O; Ecder T; Axelsson J
Clin Exp Nephrol; 2019 Sep; 23(9):1130-1140. PubMed ID: 31134465
[TBL] [Abstract][Full Text] [Related]
8. Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease.
Hwang JH; Park HC; Jeong JC; Ha Baek S; Han MY; Bang K; Cho JY; Yu SH; Yang J; Oh KH; Hwang YH; Ahn C
BMC Nephrol; 2013 Jan; 14():1. PubMed ID: 23295127
[TBL] [Abstract][Full Text] [Related]
9. Clinical study on autosomal dominant polycystic kidney disease among North Tunisians.
Hajji M; Barbouch S; Harzallah A; Hedri H; Kaaroud H; Abderrahim E; Goucha R; Hamida FB; Gorsane I; Abdallah TB
Saudi J Kidney Dis Transpl; 2019; 30(1):175-184. PubMed ID: 30804279
[TBL] [Abstract][Full Text] [Related]
10. Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana.
Okyere P; Ephraim RKD; Okyere I; Attakorah J; Serwaa D; Essuman G; Abaka-Yawson A; Adoba P
BMC Nephrol; 2021 Apr; 22(1):156. PubMed ID: 33910506
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation and outcome of autosomal dominant polycystic kidney disease in Pakistan: a single center experience.
Rabbani MA; Ali SS; Murtaza G; Ahmad B; Maria Q; Siddiqui BK; Shah SM; Ahmad A
J Pak Med Assoc; 2008 Jun; 58(6):305-9. PubMed ID: 18988388
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan.
Higashihara E; Nutahara K; Kojima M; Tamakoshi A; Yoshiyuki O; Sakai H; Kurokawa K
Nephron; 1998 Dec; 80(4):421-7. PubMed ID: 9832641
[TBL] [Abstract][Full Text] [Related]
13. Biliary Tract and Liver Complications in Polycystic Kidney Disease.
Judge PK; Harper CHS; Storey BC; Haynes R; Wilcock MJ; Staplin N; Goldacre R; Baigent C; Collier J; Goldacre M; Landray MJ; Winearls CG; Herrington WG
J Am Soc Nephrol; 2017 Sep; 28(9):2738-2748. PubMed ID: 28465378
[TBL] [Abstract][Full Text] [Related]
14. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
[TBL] [Abstract][Full Text] [Related]
15. Polycystic kidney disease: etiology, pathogenesis, and treatment.
Martinez JR; Grantham JJ
Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
[TBL] [Abstract][Full Text] [Related]
16. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
[TBL] [Abstract][Full Text] [Related]
17. Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016.
Chebib FT; Torres VE
Am J Kidney Dis; 2016 May; 67(5):792-810. PubMed ID: 26530876
[No Abstract] [Full Text] [Related]
18. Baseline characteristics of the autosomal-dominant polycystic kidney disease sub-cohort of the KoreaN cohort study for outcomes in patients with chronic kidney disease.
Kim H; Koh J; Park SK; Oh KH; Kim YH; Kim Y; Ahn C; Oh YK
Nephrology (Carlton); 2019 Apr; 24(4):422-429. PubMed ID: 29797773
[TBL] [Abstract][Full Text] [Related]
19. [Renal manifestation of Autosomal Dominant Polycystic Kidney Disease].
Galliani M; Chicca S; Vitaliano E; Di Lullo L; Giannakakis K; Paone A
G Ital Nefrol; 2018 Mar; 35(2):. PubMed ID: 29582957
[TBL] [Abstract][Full Text] [Related]
20. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
Coban M; Inci A
Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
